Long-term transvaginal ultrasonographic endometrial follow-up in postmenopausal breast cancer patients with tamoxifen treatment

Gynecologic Oncology

Volumn 74, Issue 2, 1999, Pages 222-226

  Nahari, Clariss ^a   Tepper, Ron ^a   Beyth, Yoram ^a   Flex, Dov ^b,c   Figer, Arie ^b,c   Cohen, Ilan ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Endometrium; Postmenopause; Tamoxifen; Ultrasonography

Indexed keywords

TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

EID: 0032784140     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5457     Document Type: Article

References (39)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic and immune therapy. Lancet 339:1-15, 71-85, 1992
2. Neven P, De Muylder X, Van Belle Y, Vanderick G, Ve Muylder E: Tamoxifen and the uterus and endometrium. Lancet 2:375, 1989
3. De Muylder X, Neven P, Desomer M: Endometrial lesions patients undergoing tamoxifen therapy. Int J Obstet Gynecol 36:127-129, 1991
4. Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y: Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynecol 100:567-570, 1993
5. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660-664, 1993
6. Cohen I, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y: Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185-190, 1994
7. Cohen I, Tepper R, Rosen DJD, Shapira J, Cordoba M, Altaras MM, Dror Y, Beyth Y: Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 55:138-143, 1994
8. Kedar RP, Bourne TH, Powels TJ, Collins WP, Ashley SE, Cosgrove DO: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 343:1318-1321, 1994
9. Cohen I, Altaras MM, Shapira J, Tepper R, Rosen DJD, Cordoba M, Zalel Y, Figer A, Yigael D, Beyth Y: Time-dependent effect of tamoxifen therapy on endometrial pathologies in asymptomatic, postmenopausal breast cancer patients. Int J Gynecol Pathol 15:152-157, 1996
10. Cohen I, Altaras MM, Shapira J, Tepper R, Cordoba M, Figer A, Zalel Y, Yigael D, Beyth Y: Different coexisting endometrial histological features in asymptomatic, postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 43:60-63, 1997
11. Nouvo MA, Nouvo GJ, McCaffrey RM, Levine RU, Barron B, Winkler B: Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8:125-131, 1989
12. Corley D, Rome J, Curtis MT, Hogan WM, Noumoff JC, Livolsi VA: Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111-116, 1992
13. Cohen I, Beyth Y, Bernheim J, Shapira J, Cordoba M, Aviram R, Figer A, Yigael D, Altaras MM: Different coexisting gynecological and endometrial pathologies in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 46:123-129, 1998
14. Hardell L: Tamoxifen as a risk for carcinoma of corpus uteri. Lancet 3:563, 1989
15. Fornander T, Cedermak B, Mattson R, Skoog L, Theve T, Askergen J, Rutquist LE, Glas U, Silversward C, Somell A, Wilkins N, Hjalmar MI: Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 21:117-120, 1989
16. Andersson M, Storm HH, Mouridsen HT: Incidence of new primary cancers after adjuvant tamoxifen and radiotherapy for early breast cancer. J Natl Cancer Inst 83:1013-1017, 1991
17. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML: High grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490, 1993
18. Seoud MA-F, Johnson J, Weed JC: Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82:165-169, 1993
19. Fisher B, Costantino JP, Redmond ER, Fisher EB, Wickerham L, Cronin WM: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537, 1994
20. van Leeuwen FE, Benraadt J, Coebergh JWW, Kiemeney LA, Gimbere CH, Otter R, Schouten LJ, Dambuis RA, Bontenbal M, Diepenhorst FW: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448-452, 1994
21. Barakat R, Wang G, Curtin J, Vlamis V, Hoskins WJ: Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 55:164-168, 1994
22. Rutquist LE, Johnson H, Signomaklo T, Johnson U, Fornander T, Wilking N: Adjuvant tamoxifen therapy for early stage breast cancer and second primary cancer. J Natl Cancer Inst 87:645-651, 1995
23. Cook LS, Wiess NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancer. J Natl Cancer Inst 87:1359-1364, 1995
24. Curtis RE, Boice JD Jr, Shrimer DA, Hankey BF, Fraumeni JF Jr: Second cancers after adjuvant tamoxifen therapy. J Natl Cancer Inst 88:832-834, 1996
25. Cohen I, Rosen DJD, Tepper R, Cordoba M, Shapira J, Altaras MM, Yigael D, Beyth Y: Ultrasonographic evaluation of the endometrium with correlation to endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 5:275-280, 1993
26. Tepper R, Beyth Y, Altaras MM, Zalel Y, Shapira J, Cordoba M, Cohen I: Value of sonohysterography in asymptomatic, postmenopausal tamoxifen-treated patients. Gynecol Oncol 64:386-391, 1997
27. Ciato S, Cecchini S, Bonardi R, Grozzini G: Ultrasonographic surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 244:60, 1994
28. Borenstein J, Auslender R, Pascal B, Gutterman E, Abramovici H: Diagnostic pitfalls of ultrasonographic screening in women treated with tamoxifen. J Reprod Med 39:674-678, 1994
29. Exacoustos C, Zupi E, Cangi B, Chiartti M, Arduini D, Ramanini C: Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound color flow Doppler, hysteroscopic and histologic study. Ultrasound Obstet Gynecol 6:435-442, 1995
30. Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I: A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 179:62-70, 1998
31. Hann LE, Geiss CS, Bach AM, Tao Y, Baum HJ, Barakat RR: Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR 168:657-661, 1997
32. Fleisher AC, Kallameris C, Machin JE, Entman SS, Everette James A: Sonographic depiction of normal and abnormal endometrium with histopathologic correlation. J Ultrasound Med 5:445-452, 1986
33. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119-123, 1990
34. Varner RE, Sparks JM, Cameron CD, Roberts LL, Soong S-J: Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 78:195-199, 1991
35. Nasri MN, Shepard JH, Stechell ME, Löwe DG, Chard T: The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynecol 98:470-475, 1991
36. Lin MC, Gosnic BB, Wolf SI, Feldesman MR, Stuenkel CA, Braly PS, Pretorius DH: Endometrial thickness after menopause: effect of hormone replacement. Radiology 180:427-431, 1991
37. Granberg S, Wilkind M, Karlsson B, Norstrom A, Frieberg L-G: Endometrial thickness as measured by endovagiultrasonography for identifying endometrial abnormalities. Am J Obstet Gynecol 164:47-52, 1991
38. Uzieli B, Lewin A, Brufman G, Dorrembus D, Mor-Yosef S: The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26:101-105, 1993
39. Wallgran A, Barae E, Carstensen J: Should Adjuvant Tamoxifen be Given for Several Years in Breast Cancer? in IV Jones SE, Salmon SE (eds): Adjuvant Therapy for Cancer. New York, Grune and Stratton, 1984, pp 331-337